AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
PREVENTION OF CARDIOVASCULAR-DISEASE - THE SCANDINAVIAN EXPERIENCE
Authors: PEDERSEN TR
Citation: Tr. Pedersen, PREVENTION OF CARDIOVASCULAR-DISEASE - THE SCANDINAVIAN EXPERIENCE, Aging, 10(2), 1998, pp. 167-167
DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: FAERGEMAN O KJEKSHUS J COOK T PYORALA K WILHELMSEN L THORGEIRSSON G PEDERSEN TR
Citation: O. Faergeman et al., DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), European heart journal, 19(10), 1998, pp. 1531-1537
VARIATION IN POLLEN LIMITATION AMONG PLANTS AND PHENOTYPIC SELECTION ON FLORAL TRAITS IN AN EARLY-SPRING FLOWERING HERB
Authors: TOTLAND O ANDERSEN HL BJELLAND T DAHL V EIDE W HOUGE S PEDERSEN TR VIE EU
Citation: O. Totland et al., VARIATION IN POLLEN LIMITATION AMONG PLANTS AND PHENOTYPIC SELECTION ON FLORAL TRAITS IN AN EARLY-SPRING FLOWERING HERB, Oikos, 82(3), 1998, pp. 491-501
IMPROVED SURVIVAL, REDUCED MAJOR CORONARY EVENTS AND FEWER REVASCULARIZATIONS IN SIMVASTATIN-TREATED 4S PATIENTS WITH IMPAIRED FASTING GLUCOSE
Authors: HAFFNER SM ALEXANDER CM BOCCUZZI SJ COOK TJ MUSLINER TA PEDERSEN TR KJEKSHUS J PYORALA K
Citation: Sm. Haffner et al., IMPROVED SURVIVAL, REDUCED MAJOR CORONARY EVENTS AND FEWER REVASCULARIZATIONS IN SIMVASTATIN-TREATED 4S PATIENTS WITH IMPAIRED FASTING GLUCOSE, Diabetes, 47, 1998, pp. 209-209
EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY
Authors: PEDERSEN TR WILHELMSEN L FAERGEMAN O STRANDBERG T THORGEIRSSON G TROEDSSON L KRISTIANSON J COOK TJ KJEKSHUS J
Citation: Tr. Pedersen et al., EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY, Circulation, 98(17), 1998, pp. 2370-2370
LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
Authors: PEDERSEN TR OLSSON AG FAERGEMAN O KJEKSHUS J WEDEL H BERG K WILHELMSEN L HAGHFELT T THORGEIRSSON G PYORALA K MIETTINEN T CHRISTOPHERSEN B TOBERT JA MUSLINER TA COOK TJ
Citation: Tr. Pedersen et al., LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY, Circulation, 97(15), 1998, pp. 1453-1460
EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN-SIMVASTATIN-SURVIVAL-STUDY (4S)
Authors: PEDERSEN TR KJEKSHUS J PYORALA K OLSSON AG COOK TJ MUSLINER TA TOBERT JA HAGHFELT T
Citation: Tr. Pedersen et al., EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN-SIMVASTATIN-SURVIVAL-STUDY (4S), The American journal of cardiology, 81(3), 1998, pp. 333-335
USE OF STATINS - COST-EFFECTIVENESS WAS STUDIED IN 4S STUDY
Authors: KJEKSHUS J PEDERSEN TR
Citation: J. Kjekshus et Tr. Pedersen, USE OF STATINS - COST-EFFECTIVENESS WAS STUDIED IN 4S STUDY, BMJ. British medical journal, 315(7122), 1997, pp. 1619-1620
RANDOMIZED TRIAL OF LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN) IN PREVENTION OF LEFT-VENTRICULAR THROMBUS FORMATION AND ARTERIAL EMBOLISM AFTER ACUTE ANTERIOR MYOCARDIAL-INFARCTION - THE FRAGMIN IN ACUTE MYOCARDIAL-INFARCTION (FRAMI) STUDY
Authors: KONTNY F DALE J ABILDGAARD U PEDERSEN TR
Citation: F. Kontny et al., RANDOMIZED TRIAL OF LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN) IN PREVENTION OF LEFT-VENTRICULAR THROMBUS FORMATION AND ARTERIAL EMBOLISM AFTER ACUTE ANTERIOR MYOCARDIAL-INFARCTION - THE FRAGMIN IN ACUTE MYOCARDIAL-INFARCTION (FRAMI) STUDY, Journal of the American College of Cardiology, 30(4), 1997, pp. 962-969
EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: KJEKSHUS J PEDERSEN TR PYORALA K OLSSON AG
Citation: J. Kjekshus et al., EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Journal of the American College of Cardiology, 29(2), 1997, pp. 7181-7181
CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997)
Authors: PYORALA K PEDERSEN TR KJEKSHUS J FAERGEMAN O OLSSON AG THORGEIRSSON G
Citation: K. Pyorala et al., CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997), Diabetes care, 20(6), 1997, pp. 1048-1048
CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: PYORALA K PEDERSEN TR KJEKSHUS J FAERGEMAN O OLSSON AG THORGEIRSSON G
Citation: K. Pyorala et al., CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Diabetes care, 20(4), 1997, pp. 614-620
COST-EFFECTIVENESS OF SIMVASTATIN TREATMENT TO LOWER CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE
Authors: JOHANNESSON M JONSSON B KJEKSHUS J OLSSON AG PEDERSEN TR WEDEL H
Citation: M. Johannesson et al., COST-EFFECTIVENESS OF SIMVASTATIN TREATMENT TO LOWER CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE, The New England journal of medicine, 336(5), 1997, pp. 332-336
LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: PEDERSEN TR KJEKSHUS J BERG K FAERGEMAN O MIETTINEN T OLSSON AG
Citation: Tr. Pedersen et al., LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Atherosclerosis, 130, 1997, pp. 21-21
COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: SCHWARTZ JS BROCCUZZI SJ GLICK H COOK JR KINOSIAN B DAVIS L PEDERSEN TR KJEKSHUS J
Citation: Js. Schwartz et al., COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Circulation, 96(8), 1997, pp. 2827-2827
4S RESULTS SUPPORT AHA GUIDELINES TO REDUCE LDL-CHOLESTEROL TO LESS-THAN 100 MG DL IN PATIENTS WITH CHD/
Authors: PEDERSEN TR KJEKSHUS J OLSSON AG COOK TJ
Citation: Tr. Pedersen et al., 4S RESULTS SUPPORT AHA GUIDELINES TO REDUCE LDL-CHOLESTEROL TO LESS-THAN 100 MG DL IN PATIENTS WITH CHD/, Circulation, 96(8), 1997, pp. 4019-4019
EFFECT OF PIMOBENDAN ON EXERCISE CAPACITY IN PATIENTS WITH HEART-FAILURE - MAIN RESULTS FROM THE PIMOBENDAN IN CONGESTIVE-HEART-FAILURE (PICO) TRIAL
Authors: HEYNDRICKX G RENARD M BEIL S DOERING W KAUDER E KLEPZIG H SCHACHERER C HAASS M KRUGER C LIMBOURG P LIOMIN E MAISCH B SCHARTL M SIMON H BERNINK PJLM FELS PW DOHMEN HJM DUNSELMAN PHJM BASELIER MRP HOLWERDA NJ LAARMAN GJ LEENDERS CM VANLEEUWEN K MICHELS HR VANDERENT M REMME WJ WITHAGEN AJAM GUNDERSEN T OTTERSTAD JE FROLAND G PEDERSEN TR FERREIRA JRG DESA EP SEABRAGOMES R GIL V ABDON NJ JONSSON J LUBSEN J
Citation: G. Heyndrickx et al., EFFECT OF PIMOBENDAN ON EXERCISE CAPACITY IN PATIENTS WITH HEART-FAILURE - MAIN RESULTS FROM THE PIMOBENDAN IN CONGESTIVE-HEART-FAILURE (PICO) TRIAL, HEART, 76(3), 1996, pp. 223-231
LIPID-LOWERING THERAPY FOR PATIENTS WITH OR AT RISK OF CORONARY-ARTERY DISEASE
Authors: KJEKSHUS J PEDERSEN TR TOBERT JA
Citation: J. Kjekshus et al., LIPID-LOWERING THERAPY FOR PATIENTS WITH OR AT RISK OF CORONARY-ARTERY DISEASE, Current opinion in cardiology, 11(4), 1996, pp. 418-427
PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE - IMPLICATIONS OF LIPID-LOWERING TRIALS
Authors: PEDERSEN TR
Citation: Tr. Pedersen, PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE - IMPLICATIONS OF LIPID-LOWERING TRIALS, Journal of hypertension, 14, 1996, pp. 195-200
COST-EFFECTIVENESS OF CHOLESTEROL-LOWERING - RESULTS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: JONSSON B JOHANNESSON M KJEKSHUS J OLSSON AG PEDERSEN TR WEDEL H
Citation: B. Jonsson et al., COST-EFFECTIVENESS OF CHOLESTEROL-LOWERING - RESULTS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), European heart journal, 17(7), 1996, pp. 1001-1007
BENEFITS AND RISKS OF HMG-COA REDUCTASE INHIBITORS IN THE PREVENTION OF CORONARY HEART-DISEASE - A REAPPRAISAL
Authors: PEDERSEN TR TOBERT JA
Citation: Tr. Pedersen et Ja. Tobert, BENEFITS AND RISKS OF HMG-COA REDUCTASE INHIBITORS IN THE PREVENTION OF CORONARY HEART-DISEASE - A REAPPRAISAL, Drug safety, 14(1), 1996, pp. 11-24
PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN - REPLY
Authors: PEDERSEN TR
Citation: Tr. Pedersen, PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN - REPLY, The New England journal of medicine, 334(20), 1996, pp. 1335-1335
CHOLESTEROL-LOWERING AND THE USE OF HEALTH-CARE RESOURCES - RESULTS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
Authors: PEDERSEN TR KJEKSHUS J BERG K OLSSON AG WILHELMSEN L WEDEL H PYORALA K MIETTINEN T HAGHFELT T FAERGEMAN O THORGEIRSSON G JONSSON B SCHWARTZ JS THOMSEN H NORDENO E THOMSEN B LYNGBORG K ANDERSEN GS NIELSEN F TALLERUPHUUS U MOGENSEN M EGSTRUP K SIMONSEN EH SIMONSEN I VEJBYCHRISTENSEN H SOMMER L EIDNER PO KLARHOLT E HENRIKSEN A MELLEMGAARD K LAUNBERG J FRUERGAARD P NIELSEN L MADSEN EB IBSEN H ANDERSEN U THYRRING L THOMASSEN K JENSEN G RASMUSSEN SL SKOV N HANSEN KN LARSEN ML HAASTRUP B HJAERE I THURO A SORENSEN K LETH A MUNCH M WORCK R NIELSEN B THORN AG PEDERSENBJERREGAARD O FOURNAISE B SIGURD B ENK B NIELSEN H JACOBSEN L SVENDSEN TL NOEGHOLM A MUNTER H HAUNSO S GRANDE P ERIKSEN C NIELSEN HH PINDBORG T PINDBORG J TOST H CHRISTIANSEN BD OPPENHAGEN M EGEDE F HVIDT S KJAERBY T FLEMMING L KLAUSEN I VANHANEN H STRANDBERG T HOLTTA K PASTERNAK A OKSA H SIITONEN L RIMPI R KESANIEMI A JUUSTILA H NISSILA A SAVOLAINEN M LILJA M RANTALA A RANTALA M LAINE L MANTYMAA L NISSILA A VIRKKALA L EBELING T HELIN M LEHTO S PALOMAKI P RANTALA A VOUTILAINEN E MIETTINEN H RAISANEN R SALOKANNEL A JANTUNEN A HOGNASON J THORSTEINSDOTTIR G SIGURDSSON G SVERRISSON JT HANSTEEN V KJELSBERG F BERGET K PETTERSEN R RANDI E HOLM T GUNDERSEN T ASLAKEN B ANDRESEN EH TORSVIK H PETTERSEN R FABER A INDREBO T OSE A ROTERUD T HOLSTLARSEN L WAAGE K HOLSTLARSEN E HAEREM JW AUKRUST P TORP R MAUSETH K HALLARAKER A GERDTS E GRADEK G NYGARD O VANGEN EM HANSEN HS RESFSUM AM LISTERUD S GUNDERSRUD B STENE AM AAKERVIK O KLUKKEN B LORAAS A FOSS PO HAGA A THORESEN L DRIVENES A LEM P GABRIELSEN F HESTAD S RODE R HAUG BK SKJELVAN G ELDORSEN E YTREARNE K RASMUSSEN K NERMOEN I GJESTVANG FT CHRISTIANSEN L WALBERG K TJONNDAL HA KULSENG B ROKSETH R NERGARD TV ROE MO TENSTAD O LOFSNES IL BERGSRUD U MELBERG TH VONBRANDIS C HEGRENES L BARVIK S WOIE L ABRAHAMSEN AM AARSLAND T SVANES H NOER G NORDLIE KE HANEDALEN AE OVERSKEID K SANDVEI P JOHANSEN A JOHANSEN T HOLM T LARSEN CB OSTHOLM E HEGRESTAD S REIKVAM A SOGNEN E STILIANOY E HAWKES L HOFF S NORDVIK R JORGENSEN C HJERMANN I LEREN P NARVESTAD A FAUSA D GJESTVANG FT BERGET K NORDLAND B BRUNMARK P BIORKLUND H FORSBERG H NILSSON J BERGSTROM B LAAKSONEN I VESTERMARK MB MASCHER G HAMMARSTROM E TROSELL K KARLSSON L HALLSTROM L STJERNA A SLETTE MK BERGLUND KP LINDE B AHLMARK G SAETRE H AHLBERG G SUNDKVIST K LOFMARK R GUSTAFSSON PE MICHAELI EW GUSTAFSSON E SKARFORS E RUTER G AKESSON L WAGNER F LJUNGDAHL L WAGNER V EDHAG O VOURISALO D HJELMSELL H LUNDKVIST L ANGMAN K OLSSON A SVENSSON O KUYLENSTIERNA J FRISENETTEFICH K BERGMAN E STROMBLAD H JENSEN S JONSSON E LEVIN C ODEBERG H BENGTSSON PO HOLMESSON E HEDSTAND H BOJO L OBERG S PERSSON S CLINE C LEKSELL H WIRENSTAM UB MOBERG B EKSTRAND AB NICOL P MALMROS B SAAW J ARCINI N KOBOSKO J ANEVIK IG GYLAND F LUNDH B WENNERHOLM M OLSSON C KJELLBERG J FABIANSON K FRASER T BERGKVIST I OLSSON AG BERGDAHL B FLUUR K WARJESTAM S SVENSSON KA EKHOLM L TOREBO E RYBERG A FRISELL J HEDMAN A VALLRUP L ANDERSEN G SUNDSTROM M ALBERY K FAGHER B THULIN T SVENSTAM I NORRBY A JAUP B SVENSSON L BJURMAN A SKOGLUND E DAHL G KJELLSTROM T JUHLIN P SJOOBOQUIST M SJOGREN A LOOGNA E JANSSON T FRIDEN J NILSSON O ANDERSSON PO HENRIKSSON C ELLSTROM J BRODERSSON H LUNDQUIST L ASLUND M BOMAN K JANSSON JH NORRFORS B HOGLUND C LUNDBLAD M EJDEBACK J MALMBERG K HOGSTROM S STAHL L LEIJD B FALKENBERG C BERGSTEN L STROM S ENGSTROM AC PETZ I LILJEFORS I WENNERSTROM L WIKLUND O LINDEN T BERGH CH JONSTED K BONNIER B LUNDIN Y MOLLER BH LYCKSELL M SODERSTROM M HANSSON E GILLGREN L HALLEN C STAKEBERG H BORRETZEN J HEDEN B ANDERSSON K JOHNSON O SLUNGA L JENSEN S ELANDER B LIDELL C ANDERSSON PE MARKLUND E DAHLEN M RUCKER F LOFQVIST M WANNBERG B LIM BH LARSSON O ANDERSSON G HANSSON A GOWENIUS M UGGELDAHL I URSING D HAMMARLUND P TSUPPUKA E MALMBERG L GORANSSON K HASSELGREN P INBERG KM PETTERSON S ARLIN A ULVENSTAM G JOHANSSON S WALLIN I DUDAS K ANDREASSON M TORELUND G LOVHEIM O HEMMINGSON LO GRUNDSTROM I JULIAN DG FURBERG C THOMPSON S LUBSEN J SMITH WM HUTTUNEN J ROMO M THYGESEN K LEHTO S MIETTINEN H CROW R CHRISTOPHERSEN B BUCHMAN M GRAN T COOK J GOMES D BOCCUZZI S COOK T KRISTIANSON K
Citation: Tr. Pedersen et al., CHOLESTEROL-LOWERING AND THE USE OF HEALTH-CARE RESOURCES - RESULTS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY, Circulation, 93(10), 1996, pp. 1796-1802
SAFETY AND TOLERABILITY OF CHOLESTEROL-LOWERING WITH SIMVASTATIN DURING 5 YEARS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
Authors: PEDERSEN TR BERG K COOK TJ FAERGEMAN O HAGHFELT T KJEKSHUS J MIETTINEN T MUSLINER TA OLSSON AG PYORALA K THORGEIRSSON G TOBERT JA WEDEL H WILHELMSEN L
Citation: Tr. Pedersen et al., SAFETY AND TOLERABILITY OF CHOLESTEROL-LOWERING WITH SIMVASTATIN DURING 5 YEARS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY, Archives of internal medicine, 156(18), 1996, pp. 2085-2092
SYNTHESIS OF 3'-DIALKYLAMINO-2',3'-DIDEOXYNUCLEOSIDES FROM A 2,3'-ANHYDROTHYMIDINE OR AN ALPHA,BETA-UNSATURATED ALDEHYDE
Authors: KOFOED T ALEEM AAHA JORGENSEN PT PEDERSEN TR PEDERSEN EB
Citation: T. Kofoed et al., SYNTHESIS OF 3'-DIALKYLAMINO-2',3'-DIDEOXYNUCLEOSIDES FROM A 2,3'-ANHYDROTHYMIDINE OR AN ALPHA,BETA-UNSATURATED ALDEHYDE, Acta chemica Scandinavica, 49(4), 1995, pp. 291-296
Risultati: 1-25 | 26-39